Forsight Vision 6

Company Overview

Snapshot

Founded in April 2014, Forsight Vision 6 operates with 11–50 employees. The company has raised $4 million across three funding rounds, developing an accommodating intraocular lens for cataract surgery.

Business overview

Forsight Vision 6 (FSV6) is a Health Tech & Life Sciences company focused on developing an accommodating intraocular lens (AIOL) designed to provide precise vision across all distances following cataract surgery. Its core technology involves placing the lens over the capsular bag, a differentiated approach intended to prevent the stiffening that typically impedes accommodation. The company operates within the medical devices and medical treatment & therapeutics sectors, serving patients and healthcare providers in the ophthalmology market.

Strategic signal

In September 2017, Forsight Vision 6 secured an additional $3 million in funding. This capital infusion signals continued investor confidence in the company's innovative approach to intraocular lens technology and its potential to address a significant need in the cataract surgery market, validating its development trajectory.

Company Intelligence Q&A

What is Forsight Vision 6's primary focus?

Forsight Vision 6 is developing an accommodating intraocular lens (AIOL) designed to enable precise vision across all distances after cataract surgery, differentiating its approach by placing the lens over the capsular bag.

When was Forsight Vision 6 founded?

Forsight Vision 6 was founded in April 2014 as part of the ForSight Labs ophthalmic incubator.

What was a significant funding event for Forsight Vision 6?

In September 2017, Forsight Vision 6 raised $3 million in a funding round, as reported by MassDevice.com.

What was the total capital raised by Forsight Vision 6?

Forsight Vision 6 has raised a total of $4 million across three funding rounds.

Has Forsight Vision 6 received any grants?

In December 2014, Forsight Vision 6 received a grant from the BIRD Foundation.